| scholarly article | Q13442814 |
| P2093 | author name string | Judi Minium | |
| Maricela Haghiac | |||
| Patrick Catalano | |||
| Charles Hoppel | |||
| Perrie O'Tierney-Ginn | |||
| Patricia Glazebrook | |||
| Virtu Calabuig-Navarro | |||
| Geraldine Cheyana Ranasinghe | |||
| Sylvie Hauguel de-Mouzon | |||
| P2860 | cites work | A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 |
| Metabolic Interplay between Peroxisomes and Other Subcellular Organelles Including Mitochondria and the Endoplasmic Reticulum | Q26767387 | ||
| The interaction of hepatic lipid and glucose metabolism in liver diseases | Q26827770 | ||
| Acylcarnitines: reflecting or inflicting insulin resistance? | Q27004603 | ||
| Peroxisomes take shape | Q27027175 | ||
| The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity | Q28241306 | ||
| Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis | Q28249458 | ||
| Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy | Q28551938 | ||
| Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells | Q28574936 | ||
| Ligand-activated peroxisome proliferator activated receptor gamma alters placental morphology and placental fatty acid uptake in mice | Q28586562 | ||
| CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE. | Q34002504 | ||
| Impaired mitochondrial function in human placenta with increased maternal adiposity | Q34130854 | ||
| High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease | Q34230127 | ||
| Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases | Q34253052 | ||
| Role of carnitine in disease | Q34618777 | ||
| Obesity-induced down-regulation of the mitochondrial translocator protein (TSPO) impairs placental steroid production | Q34810997 | ||
| Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis | Q34817393 | ||
| Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003-2009. | Q35584717 | ||
| Maternal size in pregnancy and body composition in children | Q36121731 | ||
| Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study | Q36246556 | ||
| Activation of phospholipase A2 is associated with generation of placental lipid signals and fetal obesity | Q36297083 | ||
| Increased placental phospholipid levels in pre-eclamptic pregnancies | Q36656099 | ||
| Effect of ω-3 supplementation on placental lipid metabolism in overweight and obese women | Q36728654 | ||
| Placental oleic acid uptake is lower in male offspring of obese women | Q36810237 | ||
| LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney | Q36870559 | ||
| Effects of labor on placental fatty acid β oxidation | Q36901587 | ||
| Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles". | Q37227910 | ||
| Pregnancy-Related Changes of Amino Acid and Acylcarnitine Concentrations: The Impact of Obesity | Q37273113 | ||
| Maternal obesity modulates intracellular lipid turnover in the human term placenta | Q37642252 | ||
| Maternal obesity is associated with a lipotoxic placental environment | Q37689149 | ||
| Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis | Q37834857 | ||
| A critical appraisal of the predictive adaptive response hypothesis. | Q37994126 | ||
| Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatty acids in hepatocytes. Effect of inhibition of carnitine palmitoyltransferase I. | Q38313263 | ||
| Modulation of fatty acid transport and metabolism by maternal obesity in the human full-term placenta | Q38325679 | ||
| Endocrine and metabolic adaptations to pregnancy; impact of obesity | Q38650329 | ||
| Obesity and Placental Function. | Q38687952 | ||
| The influence of placental metabolism on fatty acid transfer to the fetus. | Q38787748 | ||
| Lipid catabolism via CPT1 as a therapeutic target for prostate cancer | Q38966211 | ||
| Placental metabolism and its regulation in health and diabetes | Q40496414 | ||
| Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism | Q42809256 | ||
| Association of maternal prepregnancy BMI with metabolomic profile across gestation | Q43864935 | ||
| Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases | Q44312288 | ||
| Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient | Q44655007 | ||
| The effect of pre-existing maternal obesity and diabetes on placental mitochondrial content and electron transport chain activity. | Q46869311 | ||
| High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta. | Q50994794 | ||
| An evolutionary perspective on the trans-generational basis of obesity. | Q51598345 | ||
| Plasma carnitine in pregnancy | Q70815925 | ||
| The influence of maternal fat metabolism on fetal carnitine levels | Q70870284 | ||
| Anthropometric estimation of neonatal body composition | Q71552531 | ||
| Peroxisome proliferator-activated receptor-gamma and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts | Q81644180 | ||
| Validated method for the quantification of free and total carnitine, butyrobetaine, and acylcarnitines in biological samples | Q85896315 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| maternal obesity | Q108582152 | ||
| P304 | page(s) | 2543-2555 | |
| P577 | publication date | 2017-05-23 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Effect of Maternal Obesity on Placental Lipid Metabolism. | |
| P478 | volume | 158 |
| Q54978526 | Activation of AMPK in Human Placental Explants Impairs Mitochondrial Function and Cellular Metabolism. |
| Q49718449 | Greater Neonatal Fat-Free Mass and Similar Fat Mass Following a Randomized Trial to Control Excess Gestational Weight Gain |
| Q91592451 | Maternal Lipids and Fetal Overgrowth: Making Fat from Fat |
| Q45810128 | Maternal obesity alters fatty acid oxidation, AMPK activity, and associated DNA methylation in mesenchymal stem cells from human infants |
| Q91968346 | Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties |
| Q96302572 | Metabolic reprogramming by Zika virus provokes inflammation in human placenta |
| Q57286393 | Oxidative Stress Impairs Fatty Acid Oxidation and Mitochondrial Function in the Term Placenta |
| Q89708646 | Palmitate induces apoptotic cell death and inflammasome activation in human placental macrophages |
| Q96303397 | Placental Metabolomics for Assessment of Sex-specific Differences in Fetal Development During Normal Gestation |
| Q40071874 | Placental Transfer of Maternal Obesity: Identifying the Gatekeeper |
| Q52368710 | Placental mitochondrial biogenesis and function was slightly changed by gestational hypercholesterolemia in full-term pregnant women. |
| Q57416791 | Relation of placental alkaline phosphatase expression in human term placenta with maternal and offspring fat mass |
| Q92596460 | The Effects of Maternal Obesity on Porcine Placental Efficiency and Proteome |
| Q89598008 | The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth |
Search more.